Backenroth Samuel Insider Trades

Insider Trading History

Track insider trading activity for Backenroth Samuel. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Notable Labs
Notable Labs NTBL
Chief Financial Officer
Holding Value $43.4k 175,000 shares
Last Trade
Mar 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$87.9k 525,000 shares
$0.17
$0.25
Vascular Biogenics
Vascular Biogenics VBLT
Chief Financial Officer
Holding Value $81.9k 525,000 shares
Last Trade
Mar 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.16
Notable Labs
Notable Labs NTBL
Chief Financial Officer
Holding Value $130k 525,000 shares
Last Trade
Mar 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$87.9k 525,000 shares
$0.17
$0.25
Vascular Biogenics
Vascular Biogenics VBLT
Chief Financial Officer
Holding Value $27.3k 175,000 shares
Last Trade
Mar 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.16
Vascular Biogenics
Vascular Biogenics VBLT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2023 Sale
No data
No data
$0.16
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Cfo, Treasurer & Secretary
Holding Value $15.8k 41,915 shares
Last Trade
Dec 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116M 41,915 shares
$2,768.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Cfo, Treasurer & Secretary
Holding Value $4.4k 11,630 shares
Last Trade
Apr 30, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.04M 1,000 shares
$3,036.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Cfo, Treasurer & Secretary
Holding Value $292k 772,923 shares
Last Trade
Jul 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.17M 772,923 shares
$5.39
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Cfo, Treasurer & Secretary
Holding Value $0 0 shares
Last Trade
Jul 12, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$16.2k 3,000 shares
$5.39
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $132k 350,000 shares
Last Trade
Oct 16, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.62M 350,000 shares
$13.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $80.4k 212,596 shares
Last Trade
Apr 10, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.65M 121,430 shares
$13.60
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $53.4k 141,167 shares
Last Trade
Jun 20, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$136k 2,468 shares
$55.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $52.4k 138,699 shares
Last Trade
May 23, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$155k 2,500 shares
$62.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $51.5k 136,199 shares
Last Trade
Jan 07, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.4M 130,000 shares
$102.80
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $22.7k 60,000 shares
Last Trade
Mar 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2M 60,000 shares
$202.80
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $2.34k 6,199 shares
Last Trade
Feb 06, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$210k 1,500 shares
$140.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
CFO & VP Of Bus. Development
Holding Value $172k 454,700 shares
Last Trade
Feb 03, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.9M 250,000 shares
$219.40
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
CEO & VP Of Bus. Development
Holding Value $1.78k 4,699 shares
Last Trade
Jun 13, 2013 Sale
$20.9M 126,668 shares
$165.00
$0.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up